During the past decade, Clinique La Casamance conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique La Casamance" #1 collaborator was "AlpinARC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Clinique La Casamance" are "ACS - Acute Coronary Syndrome" (1 trials), "Breast Cancer" (1 trials), "Myocardial Infarction" (1 trials), "NSTEMI - Non-ST Segment Elevation MI" (1 trials) and "Pulmonary Disease, Chronic Obstructive" (1 trials). Many other conditions were trialed in "Clinique La Casamance" in a lesser frequency.

Most popular intervention types in "Clinique La Casamance" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "COBRA PzF Coronary Stent System" (1 trials) and "Tiotropium" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique La Casamance" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Clinique La Casamance". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Clinique La Casamance, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinique La Casamance, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".